Bioabsorbable everolimus-eluting stent: Phase III start

Before year end, Abbott will begin the open-label, international Phase III ABSORB EXTEND trial to evaluate its bioabsorbable everolimus-eluting stent in about 1,000 patients with complex CAD. ...